Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Catheter Cardiovasc Interv. 2020 May 6;97(1):E104–E112. doi: 10.1002/ccd.28913

TABLE 3.

Hospital outcomes in unmatched and matched cohorts

Unmatched cohorts
Matched cohorts
Variables no. (%) No COPD (n = 6,630) COPD (n = 2,495) P value No COPD (n = 2,455) COPD (n = 2,495) P value
In-hospital mortality 160 (2.4%) 65 (2.6%) .60 70 (2.9%) 65 (2.6%) .60
In-hospital morbidities
 STEMI 50 (0.8%) 45 (1.8%) <.01 25 (1.0%) 45 (1.8%) .02
 NSTEMI 85 (1.3%) 40 (1.6%) <.01 25 (1.0%) 40 (1.6%) .07
 Tamponade 30 (0.5%) 10 (0.4%) .74 20 (0.8%) 10 (0.4%) .06
 Iatrogenic cardiac complications 170 (2.6%) 80 (3.2%) .09 80 (3.3%) 80 (3.2%) .90
 Cardiogenic shock 300 (4.50%) 70 (2.80%) <.01 10 (0.4%) 30 (1.2%) <.01
 Postprocedure respiratory complication 70 (1.1%) 40 (1.6%) .03 45 (1.8%) 40 (1.6%) .54
 Pneumothorax 20 (0.30%) 25 (1.00%) <.01 10 (0.4%) 25 (1.0%) .01
 Vascular complications 90 (1.40%) 50 (2.00%) .03 20 (0.8%) 50 (2.0%) <.01
 Transfusion during the procedure 605 (9.10%) 245 (9.80%) .31 220 (9.0%) 245 (9.8%) .30
 Acute kidney injury 525 (7.9%) 165 (6.6%) .04 190 (7.7%) 165 (6.6%) .13
 Septic shock 55 (0.8%) 30 (1.2%) .09 10 (0.4%) 30 (1.2%) <.01
 Vasopressors use 90 (1.40%) 55 (2.20%) <.01 30 (1.2%) 55 (2.2%) .73
 Stroke (after procedure) 20 (0.30%) 15 (0.60%) .04 15 (0.6%) 15 (0.6%) .96
Severe disability surrogates
 Non-home discharge 855 (13.2%) 400 (16.4%) <.01 250 (10.5) 400 (16.4) <.01
 Mechanical ventilation 395 (6.0%) 195 (7.8%) <.01 125 (5.1%) 195 (7.8%) <.01
Resources utilization
 Length of stay, mean (SD), days 5.7 (9.2) 6.6 (8.3) <.01 5.1 (7.4) 6.6 (8.3) .02
 Cost of hospitalization-mean (SD), $ 204,446 (173,932) 217,970 (150,018) <.01 194,939 (167,692) 217,225 (149,564) .03

Abbreviations: COPD; chronic obstructive pulmonary disease, STEMI; ST-segment elevation myocardial infarction; NSTEMI; non-St-segment elevation myocardial infarction.